Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27767879 | 0.98 | LMNA (0.42) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL26517700 | 0.98 | LMNA (0.42) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL820772 | 0.89 | CYP4F2 (0.46) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL821076 | 0.82 | TSHR (0.53) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL869080 | 0.82 | TSHR (0.53) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL869082 | 0.82 | TSHR (0.53) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL17676486 | 0.81 | OXER1 (0.51) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL820777 | 0.81 | OXER1 (0.51) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL16580123 | 0.81 | OXER1 (0.51) | LMNAALDH1A1CYP4F2CYP4A11TSHR | |
| SCHEMBL17720224 | 0.81 | MGAM (0.46) | LMNAALDH1A1CYP4F2CYP4A11TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | APEIRON SYNTHESIS S.A. (PL) | 2023-10-12 | — | — | US | disclosed |
| US-9738631-B2 | Compositions and methods for the treatment of neurological disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-08-22 | — | — | US | disclosed |
| US-9242939-B2 | Compositions and methods for the treatment of respiratory disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2016-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | CYP4F11, CYP4F3, CYP4F12 | LMNA 3971/4885ALDH1A1 1063/4885CYP4F2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.